Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct;17(10):592.
doi: 10.1038/s41571-020-0425-8.

CAR T cells are active in Hodgkin lymphoma

David Killock  1
Affiliations
Comment

CAR T cells are active in Hodgkin lymphoma

David Killock. Nat Rev Clin Oncol. 2020 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
    Ramos CA, Grover NS, Beaven AW, Lulla PD, Wu MF, Ivanova A, Wang T, Shea TC, Rooney CM, Dittus C, Park SI, Gee AP, Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, Grilley BJ, Morrison K, Brenner MK, Serody JS, Dotti G, Heslop HE, Savoldo B. Ramos CA, et al. J Clin Oncol. 2020 Nov 10;38(32):3794-3804. doi: 10.1200/JCO.20.01342. Epub 2020 Jul 23. J Clin Oncol. 2020. PMID: 32701411 Free PMC article. Clinical Trial.

References

Original article
    1. Ramos, C. A. et al. Anti-CD30 CAR-T Cell therapy in relapsed and refractory Hodgkin lymphoma. J. Clin. Oncol. https://doi.org/10.1200/JCO.20.01342 (2020) - DOI - PubMed

Substances

LinkOut - more resources